Home Tags Series B Extension Funding

Series B Extension Funding

Halda Therapeutics, a biotechnology company developing a novel class of cancer therapies called RIPTACTM (Regulated Induced Proximity TArgeting Chimeras) therapeutics, announced that it has raised new financing of $126 million in a Series B extension, including funding from new investors Deep Track Capital, Frazier Life Sciences, RA Capital Management, Vida Ventures, Boxer Capital and Taiho Ventures.

[Funding News] Halda Therapeutics Secures $126 Million in Series B Extension Funding...

Team SR -
© Copyright startuprise 2024 All Rights Reserved.
Exit mobile version